News articles

New target for macular degeneration gets funding for clinical trials

A new clinical research trial using a humanised monoclonal antibody to treat patients with AMD will start in 2018.

Blepharospasm web chat

In the run up to Blepharospasm Day, Moorfields is hosting a web chat on Monday 16 November, 1–2pm.

New chief executive for Moorfields Eye Hospital

We are pleased to announce the appointment of David Probert as Moorfields’ new chief executive.

Blepharospasm Day

Your chance to learn and ask questions about blepharospasm on Saturday 21 November.

World Sight Day 2015 at Moorfields

World Sight Day is an annual event that focuses on raising attention on blindness and vision impairment.

Moorfields in the vanguard of new NHS hospitals collaboration drive

Moorfields Eye Hospital is 1 of 13 new hospital vanguards selected by NHS England to develop new models of care.

New trial for wet AMD

A new trial treatment for ‘wet’ age-related macular degeneration (AMD) has begun at Moorfields.

AMD research trial

The AMD stem cell trial is not open to volunteers due to strict criteria and ethical guidelines at this point.